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CDC and Fungal Diseases
W hy are funga l diseases a pub lic  health issue?
Fungal diseases pose an increasing th rea t to  pub lic health fo r several reasons.
Opportunistic infections such as cryptococcosis and aspergillosis are becom ing increasingly 
problem atic as the num ber o f people w ith  weakened im m une systems rises -  th is includes cancer 
patients, transplant recipients, and people w ith  HIV/AIDS.
Hospital-associated infections such as candidemia are a leading cause o f b loodstream  infections in 
the United States. Advancem ents and changes in healthcare practices can provide opportun ities  for 
new and drug-resistant fung i to  em erge in hospital settings.
Community-acquired infections such as coccidioidom ycosis (Valley Fever), blastomycosis, and 
histoplasmosis, are caused by fung i th a t are abundant in the environm ent. These types o f fung i live 
in the soil, on plants, or in com post heaps, and are endem ic (native and com m on) th ro u g h o u t much 
o f the  U.S. Climate change may be affecting these fungi, as even small changes in tem pera ture  or 
m oisture can affect the ir grow th.
C urrent challenges:
• Defining the public health burden o f em erging 
fungal diseases• Developing improved methods fo r earlier 
diagnosis o f disease• Understanding the reasons for the rising number of endemic fungal infections• Determining the effects of climate change on fungi• Identifying groups of people at risk in order to  
help focus our prevention efforts
Map o f U.S. endem ic fung i
W hat is CDC do ing  to  
com bat funga l diseases?
We are taking action to  decrease the public 
health burden o f fungal diseases th ro ugh  a 
varie ty o f dom estic and international 
activities:
Responding to outbreaks w ith  
ep idem io log ic investigations Monitoring long-te rm  trends in fungal 
diseases th rough  surveillance Developing, evaluating, and promoting 
cost-effective prevention guidelines and 
in te rvention strategies Conducting laboratory activities tha t are 
vital to  outbreak investigations and 
surveillance studies Equipping laboratories in developing 
countries to  perform  diagnostic tests
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A  n e w  s tra te g y  to  p re v e n t d e a th s  f ro m
C r y p to c o c c u s
In people w ith  weakened im m une systems, the fungus Cryptococcus 
neoformans causes life-threatening m eningeal infections in nearly a 
m illion people every year. Cryptococcus is the m ost com m on cause o f 
meningitis in sub-Saharan Africa, and is a leading cause o f death am ong 
people w ith  HIV. It is not possible to  prevent the  in itia l in fection, bu t a 
b lood test fo r cryptococcal antigen can catch the infection before 
m eningitis develops. A novel, point-of-care d ipstick test is quick, simple, 
affordable, and effective. CDC's call to  action is to  equ ip half o f all HIV 
clinics in Africa and Asia to  perform  Cryptococcus testing and trea tm ent 
by 2015, which could save 50,000 -  100,000 lives every year.
M o n ito r in g  h o s p ita l-a s s o c ia te d  C a n d id a  b lo o d s tre a m  
in fe c t io n s  w ith  m u lt i-s ta te  s u rv e illa n c e
Candida is the  th ird  m ost com m on cause o f hospital-associated bloodstream  
infections in the U.S. Since 2008, CDC has been conducting population-based, 
active laboratory surveillance in several U.S. locations in order to  m on ito r the 
ep idem io logy o f candidem ia as well as trends in drug resistance among 
d iffe ren t Candida species. Results o f the ongo ing  surveillance indicate tha t the 
incidence o f candidemia has increased among some age groups in recent years, 
and that species o f Candida may be becom ing resistant to  particular antifungal 
medications. CDC has identified im proved adherence to  infection prevention 
guidelines and im proved national surveillance as tw o  im po rtan t healthcare- 
associated infection prevention "W innable Battle" goals.
"D is e a s e  d e te c t iv e s :"  re s p o n d in g  to  
o u tb re a k s  o f  fu n g a l in fe c t io n s
Responding to  outbreaks is an integral part o f CDC's efforts to  prevent 
and contro l the  burden o f em erging fungal infections. Recently, CDC 
responded to  an outbreak o f  mucormycosis skin and soft-tissue 
infections am ong to rnado  victim s in Joplin, Missouri. W orking side-by- 
side w ith  members o f the com m unity, disaster relief agencies, and state 
and local health departm ents, CDC reviewed medical records and 
conducted interviews in order to  find  o u t w hy some people g o t the 
infection and others did not. U ltim ately, th ro u g h  collaboration w ith  a 
varie ty o f partners, the goal o f any outbreak investigation is to  learn 
how  to  better recognize and prevent these types o f infections in the 
future.
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